AT296252B - Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten und deren Säureadditionssalzen - Google Patents

Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten und deren Säureadditionssalzen

Info

Publication number
AT296252B
AT296252B AT995670A AT995670A AT296252B AT 296252 B AT296252 B AT 296252B AT 995670 A AT995670 A AT 995670A AT 995670 A AT995670 A AT 995670A AT 296252 B AT296252 B AT 296252B
Authority
AT
Austria
Prior art keywords
acyl
preparation
new
acid addition
addition salts
Prior art date
Application number
AT995670A
Other languages
German (de)
English (en)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of AT296252B publication Critical patent/AT296252B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT995670A 1968-03-30 1969-03-19 Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten und deren Säureadditionssalzen AT296252B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000343 1968-03-30

Publications (1)

Publication Number Publication Date
AT296252B true AT296252B (de) 1972-02-10

Family

ID=11000825

Family Applications (2)

Application Number Title Priority Date Filing Date
AT268469A AT293358B (de) 1968-03-30 1969-03-19 Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten
AT995670A AT296252B (de) 1968-03-30 1969-03-19 Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten und deren Säureadditionssalzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT268469A AT293358B (de) 1968-03-30 1969-03-19 Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten

Country Status (10)

Country Link
US (1) US3642805A (US08177716-20120515-C00003.png)
JP (1) JPS4843726B1 (US08177716-20120515-C00003.png)
AT (2) AT293358B (US08177716-20120515-C00003.png)
CH (1) CH510620A (US08177716-20120515-C00003.png)
DE (1) DE1916481C3 (US08177716-20120515-C00003.png)
DK (1) DK126426B (US08177716-20120515-C00003.png)
FR (1) FR2007354B1 (US08177716-20120515-C00003.png)
GB (1) GB1240224A (US08177716-20120515-C00003.png)
NL (1) NL6904889A (US08177716-20120515-C00003.png)
SE (1) SE375760B (US08177716-20120515-C00003.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322987A (en) * 1969-12-29 1973-07-11 Richter Gedeon Vegyeszet On,n-diacylhydroxylamine derivatives and preparation
US4028401A (en) * 1976-07-01 1977-06-07 Morton-Norwich Products, Inc. (Substituted)ureidoacetohydroxamic acids
US4496541A (en) * 1983-01-12 1985-01-29 Usv Pharmaceutical Corporation Compounds for treating hypertension
JPS6321067U (US08177716-20120515-C00003.png) * 1986-07-26 1988-02-12
US5228899A (en) * 1989-08-25 1993-07-20 Sumitomo Chemical Company Limited Hydroxamic acid esters and plant growth regulation therewith
US5254724A (en) * 1991-10-30 1993-10-19 University Of Florida Research Foundation, Inc. Method for synthesis of desferrioxamine B, analogs and homologs thereof
DE10007308A1 (de) * 2000-02-17 2001-08-23 Bosch Gmbh Robert Verfahren und Vorrichtung zur Ermittlung der verbleibenden Betriebsdauer eines Produktes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1167934A (fr) * 1955-06-28 1958-12-03 Hoffmann La Roche Procédé pour la préparation de nouveaux dérivés d'alpha-amino-beta-hydroxy-acides

Also Published As

Publication number Publication date
DE1916481B2 (de) 1973-11-29
SE375760B (US08177716-20120515-C00003.png) 1975-04-28
DK126426B (da) 1973-07-16
US3642805A (en) 1972-02-15
GB1240224A (en) 1971-07-21
DE1916481A1 (de) 1969-10-09
CH510620A (de) 1971-07-31
NL6904889A (US08177716-20120515-C00003.png) 1969-10-02
AT293358B (de) 1971-10-11
FR2007354B1 (US08177716-20120515-C00003.png) 1974-01-11
DE1916481C3 (de) 1974-06-27
FR2007354A1 (US08177716-20120515-C00003.png) 1970-01-09
JPS4843726B1 (US08177716-20120515-C00003.png) 1973-12-20

Similar Documents

Publication Publication Date Title
AT317211B (de) Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten und von deren Salzen
AT294086B (de) Verfahren zur Herstellung von neuen 5-Phenyltetrazol-Derivaten und deren Salzen
AT298485B (de) Verfahren zur Herstellung von neuen Imidazolinderivaten und deren Säureadditionssalzen
AT289115B (de) Verfahren zur Herstellung von neuen Piperidinderivaten und von deren Säureadditionssalzen
AT305249B (de) Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-aminopropanen und von deren Säureadditionssalzen
AT309463B (de) Verfahren zur Herstellung von neuen Dialkylxanthinderivaten und deren Salzen
AT307380B (de) Verfahren zur Herstellung von neuen Aminoalkyladamantanen und deren Säureadditionssalzen
AT293419B (de) Verfahren zur Herstellung von neuen 1-Carbamyl-3-phenylpyrrolidinen und deren Säureadditionssalzen
AT308123B (de) Verfahren zur Herstellung von neuen Thienobenzothiazepinderivaten und von deren Säureadditionssalzen
AT296252B (de) Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten und deren Säureadditionssalzen
CH522639A (de) Verfahren zur Herstellung von 3-Indolylessigsäurederivaten und deren Salzen
AT298495B (de) Verfahren zur Herstellung von neuen Diallylaminoalkanoylamiden und von deren Säureadditionssalzen
AT317901B (de) Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten und deren Säureadditionssalzen
AT321265B (de) Verfahren zur Herstellung von neuen Benzobicycloalkanaminen und deren Säureadditionssalzen
AT287727B (de) Verfahren zur Herstellung von neuen Piperazinderivaten und von deren Saureadditionssalze
AT310156B (de) Verfahren zur Herstellung von neuen Thienyl-imidazolyl-fettsäurederivaten und deren Salzen
AT302994B (de) Verfahren zur Herstellung von neuen N-Aminoäthoxyacetyl-aminoadamantanen und deren Säureadditionssalzen
AT289106B (de) Verfahren zur Herstellung von neuen 1-Pyridyl-2-imidazolonen und deren Säureadditionssalzen
AT287717B (de) Verfahren zur Herstellung von neuen Piperidinderivaten und von deren Säureadditionssalzen
AT303034B (de) Verfahren zur Herstellung von neuen Imidazolinderivaten und von deren Säureadditionssalzen
AT310143B (de) Verfahren zur Herstellung von neuen 1-Acylaminoalkylphenoxy-2- -hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen
AT294094B (de) Verfahren zur Herstellung von neuen Cycloalkanochinolonderivaten und deren Salzen
AT305250B (de) Verfahren zur Herstellung von neuen 1-Hydroxyphenyl-1-hydroxy-2-(3-aryl-3-hydroxypropyl)-aminoäthanen und von deren Säureadditionssalzen
AT305246B (de) Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-aminopropanen und von deren Säureadditionssalzen
AT289092B (de) Verfahren zur Herstellung von neuen Aminobenzocycloalkylnitrilen und deren Salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee